Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Secret Central Bank Gold Transfer - Operation Fish

“Gold is a relic of barbarism and should be discarded by all civilized nations as a medium of exchange.” -John T. Goss, addressing the U.S. Senate in 1894 By the early summer of 1940, Belgium and the Netherlands were defeated. France w...
Marin Katusa | March 15, 2019 |

The Oil Crisis Saudi Arabia Can't Solve

Saudi Arabia's CEO Amin Nasr's message to the press that oil flows to the market are guaranteed, should be taken with a pinch of salt. Looking at the current volatility in the Persian/Arabian Gulf and the possibility of a temporary closure of the Strait of Hormuz, the Ar...
Cyril Widdershoven | July 2, 2019 |

Technical Analyst: Medical Device Stock Looking Set to Reverse

Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery. This is an interesting story. Without going into more detail than is necessary, Imagin Me...
Streetwise Reports | July 15, 2019 |

The Oil Crisis Saudi Arabia Can't Solve

Saudi Arabia's CEO Amin Nasr's message to the press that oil flows to the market are guaranteed, should be taken with a pinch of salt. Looking at the current volatility in the Persian/Arabian Gulf and the possibility of a temporary closure of the Strait of Hormuz, the Ar...
Cyril Widdershoven | July 23, 2019 |

Buzz on the Bullboards: Who’s taking off and who’s grounded

We are just around the corner from the end of the personal fiscal year, and signs of increased activity are wherever you look. Those who are looking to cash in, or brokers looking for a couple of solid deals, are making their last-minute moves while companies look to ...
Jonathon Brown | December 7, 2023 |

VIDEO: Mine Gold Without Mining? ELY Gold talks Nevada

Want to mine Gold without mining? - Royalty companies receive streams of cash from a business in exchange for cash upfront or land usage — it is relatively easy to understand. They also often pay healthy dividends; which income investors can appreciate. Developing a...
Stockhouse Media | August 28, 2019 |

How a junior copper and gold explorer added the coveted Santa Cecilia project to its portfolio

The copper price has had a booming 2021 — having reached an all-time high of US$4.90 in May of this year — and companies in the space have been reaping the benefits of this year’s hottest metal. Meet Vancouver, BC-based Torq Resources Inc. ( TSXV:TORQ ,...
Jocelyn Aspa | November 12, 2021 |

Biopharma's New License Agreement with Gilead 'Brings Strong Validation and Economics'

The specifics and benefits of the deal are discussed in an H.C. Wainwright & Co. report. In a July 22 research note, H.C. Wainwright & Co. analyst Ed Arce reported that DURECT Corp. (DRRX:NASDAQ) entered an agreement concerning its SABER technology and SAB...
Streetwise Reports | July 24, 2019 |

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News

Shares of migraine treatment research firm Alder BioPharmaceuticals opened 84% higher today after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. Early this morning, clinical-stage biopharmaceutical company Alder BioPharmaceu...
Streetwise Reports | September 17, 2019 |

Immuno-Oncology Firm Expands Agreement with AbbVie

The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report. In a Nov. 21 research note, ROTH Capital Partners analyst Zegbeh Jallah reported that Harpoon Therapeutics Inc. (HARP:NASDAQ) and AbbVie Inc. (ABBV...
Streetwise Reports | December 5, 2019 |
1 2 3 4 5 6 7 8 9